Dr. Seungmin Lee presents clinical findings on three ECM-based materials at the 2026 KACS Fall Academic Conference.
Dr. Seungmin Lee, Key Opinion Leader for Re2O, presented findings from a clinical comparison of three extracellular matrix (ECM)-based materials at the 2026 KACS Fall Academic Conference, held on October 25 at COEX in Seoul, South Korea.
The presentation, titled “The Power of ECM in Determining Skin Density: Clinical Reality, Comparison of Three ECM-Based Materials,” explored the fundamental properties of ECM, its role in skin tissue, and key considerations for interpreting clinical data on ECM-based materials.
The presentation also covered clinical findings from a comparison of three ECM-based materials. The discussion addressed differences in material characteristics and observed outcome measures, emphasizing the importance of considering study conditions and evaluation criteria when interpreting comparative data. Findings from limited clinical observations should be interpreted within the scope of the available evidence rather than generalized to overall effectiveness or long-term outcomes.
The presentation focused on examining the characteristics of ECM-based materials alongside clinical data to provide a broader perspective on skin tissue. It also highlighted the importance of considering ECM composition, structure, and interactions within the tissue environment rather than viewing individual components in isolation.
Dr. Lee continues his clinical and academic work in the field of ECM as a Key Opinion Leader for Re2O. His presentation at the conference provided an opportunity to share clinical comparison findings and perspectives on ECM-based materials.